313 related articles for article (PubMed ID: 20522789)
1. Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.
Hecker M; Zaslona Z; Kwapiszewska G; Niess G; Zakrzewicz A; Hergenreider E; Wilhelm J; Marsh LM; Sedding D; Klepetko W; Lohmeyer J; Dimmeler S; Seeger W; Weissmann N; Schermuly RT; Kneidinger N; Eickelberg O; Morty RE
Am J Respir Crit Care Med; 2010 Sep; 182(6):805-18. PubMed ID: 20522789
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
Kouri FM; Queisser MA; Königshoff M; Chrobak I; Preissner KT; Seeger W; Eickelberg O
Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
4. Altered nano/micro-order elasticity of pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.
Nakamura K; Shimizu J; Kataoka N; Hashimoto K; Ikeda T; Fujio H; Ohta-Ogo K; Ogawa A; Miura A; Mohri S; Nagase S; Morita H; Kusano KF; Date H; Matsubara H; Mochizuki S; Hashimoto K; Kajiya F; Ohe T
Int J Cardiol; 2010 Apr; 140(1):102-7. PubMed ID: 19073348
[TBL] [Abstract][Full Text] [Related]
5. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
Yamamura A; Guo Q; Yamamura H; Zimnicka AM; Pohl NM; Smith KA; Fernandez RA; Zeifman A; Makino A; Dong H; Yuan JX
Circ Res; 2012 Aug; 111(4):469-81. PubMed ID: 22730443
[TBL] [Abstract][Full Text] [Related]
7. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
Jachec W; Foremny A; Domal-Kwiatkowska D; Smolik S; Tomasik A; Mazurek U; Wodniecki J
Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
[TBL] [Abstract][Full Text] [Related]
8. BDNF/TrkB signaling augments smooth muscle cell proliferation in pulmonary hypertension.
Kwapiszewska G; Chwalek K; Marsh LM; Wygrecka M; Wilhelm J; Best J; Egemnazarov B; Weisel FC; Osswald SL; Schermuly RT; Olschewski A; Seeger W; Weissmann N; Eickelberg O; Fink L
Am J Pathol; 2012 Dec; 181(6):2018-29. PubMed ID: 23058367
[TBL] [Abstract][Full Text] [Related]
9. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
10. IL-13 receptor alpha2 promotes epithelial cell regeneration from radiation-induced small intestinal injury in mice.
Kawashima R; Kawamura YI; Kato R; Mizutani N; Toyama-Sorimachi N; Dohi T
Gastroenterology; 2006 Jul; 131(1):130-41. PubMed ID: 16831597
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of simvastatin on platelet-derived growth factor signaling in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
Ikeda T; Nakamura K; Akagi S; Kusano KF; Matsubara H; Fujio H; Ogawa A; Miura A; Miura D; Oto T; Yamanaka R; Otsuka F; Date H; Ohe T; Ito H
J Cardiovasc Pharmacol; 2010 Jan; 55(1):39-48. PubMed ID: 19786891
[TBL] [Abstract][Full Text] [Related]
12. Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension.
Patel HH; Zhang S; Murray F; Suda RY; Head BP; Yokoyama U; Swaney JS; Niesman IR; Schermuly RT; Pullamsetti SS; Thistlethwaite PA; Miyanohara A; Farquhar MG; Yuan JX; Insel PA
FASEB J; 2007 Sep; 21(11):2970-9. PubMed ID: 17470567
[TBL] [Abstract][Full Text] [Related]
13. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.
Dai J; Zhou Q; Tang H; Chen T; Li J; Raychaudhuri P; Yuan JX; Zhou G
Cell Signal; 2018 Nov; 51():119-129. PubMed ID: 30092353
[TBL] [Abstract][Full Text] [Related]
14. Endothelin A receptor blockade improves regression of flow-induced pulmonary vasculopathy in piglets.
Mercier O; Sage E; Izziki M; Humbert M; Dartevelle P; Eddahibi S; Fadel E
J Thorac Cardiovasc Surg; 2010 Sep; 140(3):677-83. PubMed ID: 20723731
[TBL] [Abstract][Full Text] [Related]
15. Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension.
Papakonstantinou E; Kouri FM; Karakiulakis G; Klagas I; Eickelberg O
Eur Respir J; 2008 Dec; 32(6):1504-12. PubMed ID: 18768572
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats.
Dai YP; Bongalon S; Tian H; Parks SD; Mutafova-Yambolieva VN; Yamboliev IA
Vascul Pharmacol; 2006 May; 44(5):275-82. PubMed ID: 16524786
[TBL] [Abstract][Full Text] [Related]
17. Flow shear stress enhances intracellular Ca2+ signaling in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension.
Song S; Yamamura A; Yamamura H; Ayon RJ; Smith KA; Tang H; Makino A; Yuan JX
Am J Physiol Cell Physiol; 2014 Aug; 307(4):C373-83. PubMed ID: 24920677
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
Schermuly RT; Pullamsetti SS; Kwapiszewska G; Dumitrascu R; Tian X; Weissmann N; Ghofrani HA; Kaulen C; Dunkern T; Schudt C; Voswinckel R; Zhou J; Samidurai A; Klepetko W; Paddenberg R; Kummer W; Seeger W; Grimminger F
Circulation; 2007 May; 115(17):2331-9. PubMed ID: 17438150
[TBL] [Abstract][Full Text] [Related]
19. LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension.
Zucker MM; Wujak L; Gungl A; Didiasova M; Kosanovic D; Petrovic A; Klepetko W; Schermuly RT; Kwapiszewska G; Schaefer L; Wygrecka M
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1604-1616. PubMed ID: 30910704
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 upregulates expression of KDR and stimulates proliferation of human cerebrovascular smooth muscle cells.
Yao JS; Zhai W; Fan Y; Lawton MT; Barbaro NM; Young WL; Yang GY
J Cereb Blood Flow Metab; 2007 Mar; 27(3):510-20. PubMed ID: 16820800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
